Trade OPKO Health, Inc. - OPK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0180 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.666 |
| Open | 1.706 |
| 1-Year Change | 68% |
| Day's Range | 1.666 - 1.726 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 1.6660 | -0.0100 | -0.60% | 1.6760 | 1.7260 | 1.6660 |
| Feb 20, 2025 | 1.6660 | 0.0000 | 0.00% | 1.6660 | 1.7060 | 1.6560 |
| Feb 19, 2025 | 1.6860 | -0.0400 | -2.32% | 1.7260 | 1.7260 | 1.6860 |
| Feb 18, 2025 | 1.7160 | 0.0900 | 5.54% | 1.6260 | 1.7260 | 1.6260 |
| Feb 14, 2025 | 1.6360 | -0.0100 | -0.61% | 1.6460 | 1.6460 | 1.6160 |
| Feb 13, 2025 | 1.6460 | 0.0400 | 2.49% | 1.6060 | 1.6460 | 1.6060 |
| Feb 12, 2025 | 1.6260 | 0.0200 | 1.25% | 1.6060 | 1.6360 | 1.5860 |
| Feb 11, 2025 | 1.6160 | -0.0300 | -1.82% | 1.6460 | 1.6660 | 1.5960 |
| Feb 10, 2025 | 1.6460 | 0.0400 | 2.49% | 1.6060 | 1.6460 | 1.6060 |
| Feb 7, 2025 | 1.6060 | 0.0200 | 1.26% | 1.5860 | 1.6260 | 1.5760 |
| Feb 6, 2025 | 1.6060 | 0.0000 | 0.00% | 1.6060 | 1.6460 | 1.5860 |
| Feb 5, 2025 | 1.5960 | 0.0200 | 1.27% | 1.5760 | 1.6060 | 1.5560 |
| Feb 4, 2025 | 1.5360 | 0.0500 | 3.36% | 1.4860 | 1.5760 | 1.4860 |
| Feb 3, 2025 | 1.4960 | 0.0100 | 0.67% | 1.4860 | 1.5060 | 1.4660 |
| Jan 31, 2025 | 1.4960 | 0.0100 | 0.67% | 1.4860 | 1.5260 | 1.4860 |
| Jan 30, 2025 | 1.4960 | -0.0100 | -0.66% | 1.5060 | 1.5260 | 1.4860 |
| Jan 29, 2025 | 1.4960 | 0.0100 | 0.67% | 1.4860 | 1.5060 | 1.4760 |
| Jan 28, 2025 | 1.4760 | 0.0000 | 0.00% | 1.4760 | 1.5060 | 1.4560 |
| Jan 27, 2025 | 1.4660 | 0.0100 | 0.69% | 1.4560 | 1.4760 | 1.4560 |
| Jan 24, 2025 | 1.4760 | 0.0100 | 0.68% | 1.4660 | 1.4860 | 1.4560 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
OPKO Health, Inc. Company profile
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company''s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women''s health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services. The company''s Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. It also specialty active pharmaceutical ingredients; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.| Industry: | Medical & Diagnostic Laboratories |
4400 Biscayne Blvd.
MIAMI
FLORIDA 33137
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com